Lisa J Rogo Gupta, MD
Obstetrics/Gynecology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
16 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gupta’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A112537 · Current
Licensed to practise in California · since 2010 · expires 2027-11-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$42,728
Medicare paid this office $42,728 for 203 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 59 | $5,610 | $81 |
| Short return visit (20+ min) | 71 | $4,387 | $51 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $4,118 | $133 |
| New patient visit (45+ min) | 33 | $3,366 | $102 |
| New patient visit (45+ min) | 14 | $1,820 | $130 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
203 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 10% · Women 100% · Also on Medicaid 14% · Health risk score 1.03. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 63% · Depression 26% · Coronary heart disease 25% · Diabetes 21% · Cancer 17% · Chronic kidney disease 15% · Heart failure 8% · COPD 8% · Stroke 7% · Atrial fibrillation 6%.
The office billed $345,651, Medicare allowed $58,125 and paid $42,728; for 368 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 203 | 368 | 75 | 1.03 | $345,651 | $42,728 |
| 2023 | 188 | 342 | 75 | 1.01 | $391,822 | $44,005 |
| 2022 | 200 | 396 | 73 | 0.92 | $454,060 | $45,899 |
| 2021 | 178 | 364 | 73 | 0.96 | $331,048 | $44,176 |
| 2020 | 184 | 369 | 73 | 1.04 | $200,629 | $34,163 |
| 2019 | 326 | 606 | 71 | 1.15 | $230,713 | $46,146 |
| 2018 | 233 | 488 | 73 | 1.22 | $352,703 | $57,525 |
| 2017 | 237 | 492 | 71 | 1.31 | $317,153 | $50,685 |
| 2016 | 237 | 468 | 71 | 1.15 | $350,819 | $55,032 |
| 2015 | 132 | 239 | 73 | 1.11 | $206,882 | $28,620 |
| 2014 | 146 | 372 | 72 | 1.28 | $292,925 | $43,352 |
| 2013 | 75 | 180 | 70 | 1.10 | $96,091 | $13,361 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 102 | $6,832 | $56 |
| Repair of pelvic ligaments through vagina | 11 | $6,069 | $552 |
| New patient visit (45+ min) | 36 | $4,040 | $112 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 13 | $2,241 | $125 |
| New patient visit (30+ min) | 33 | $2,023 | $61 |
| Short return visit | 22 | $602 | $26 |
2022: 9 services
| Short return visit (20+ min) | 105 | $7,250 | $55 |
| New patient visit (45+ min) | 41 | $3,756 | $92 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 19 | $2,279 | $109 |
| New patient visit (30+ min) | 29 | $2,101 | $72 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 14 | $1,566 | $112 |
| Insertion of device into abdomen with pressure and urine flow rate study | 14 | $505 | $36 |
| Short return visit | 14 | $352 | $25 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $237 | $17 |
| Electronic assessment of bladder emptying | 13 | $50 | $4 |
2021: 6 services
| Short return visit (20+ min) | 97 | $6,495 | $53 |
| New patient visit (45+ min) | 45 | $5,046 | $112 |
| Return visit (30+ min) | 14 | $1,187 | $79 |
| New patient visit (30+ min) | 18 | $1,120 | $62 |
| Short return visit | 24 | $788 | $27 |
| Electronic assessment of bladder emptying | 12 | $59 | $5 |
2020: 4 services
| Short return visit (20+ min) | 85 | $4,942 | $44 |
| New patient visit (45+ min) | 42 | $4,342 | $103 |
| New patient visit (60+ min) | 13 | $1,817 | $140 |
| Short return visit | 40 | $897 | $16 |
2019: 11 services
| New patient visit (45+ min) | 59 | $6,040 | $102 |
| Short return visit (20+ min) | 111 | $5,959 | $44 |
| New patient visit (60+ min) | 20 | $2,652 | $133 |
| Short return visit | 92 | $2,561 | $21 |
| New patient visit (30+ min) | 33 | $2,057 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $984 | $32 |
| Return visit (30+ min) | 14 | $933 | $67 |
| Diagnostic exam of bladder and urethra using an endoscope | 12 | $854 | $71 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 16 | $347 | $22 |
| Fitting and insertion of vaginal support device | 13 | $277 | $20 |
| Electronic assessment of bladder emptying | 11 | $50 | $5 |
2018: 8 services
| New patient visit (60+ min) | 63 | $8,682 | $138 |
| New patient visit (45+ min) | 39 | $4,172 | $107 |
| Repair of pelvic ligaments through vagina | 11 | $3,192 | $290 |
| Short return visit (20+ min) | 57 | $2,488 | $42 |
| Short return visit | 76 | $2,344 | $22 |
| New patient visit (30+ min) | 16 | $1,088 | $68 |
| Diagnostic exam of bladder and urethra using an endoscope | 12 | $895 | $75 |
| Fitting and insertion of vaginal support device | 20 | $826 | $38 |
2017: 9 services
| New patient visit (60+ min) | 48 | $6,005 | $125 |
| New patient visit (45+ min) | 34 | $3,391 | $100 |
| Short return visit | 73 | $2,181 | $20 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $1,754 | $88 |
| Short return visit (20+ min) | 40 | $1,643 | $40 |
| Long return visit (40+ min) | 13 | $1,295 | $100 |
| Short return visit | 22 | $882 | $21 |
| Fitting and insertion of vaginal support device | 17 | $770 | $37 |
| Short return visit (20+ min) | 14 | $590 | $39 |
2016: 10 services
| New patient visit (60+ min) | 50 | $7,257 | $145 |
| New patient visit (45+ min) | 52 | $5,317 | $102 |
| Short return visit (20+ min) | 36 | $1,779 | $42 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $1,489 | $106 |
| New patient visit (45+ min) | 14 | $1,293 | $92 |
| Long return visit (40+ min) | 13 | $1,288 | $99 |
| Fitting and insertion of vaginal support device | 30 | $1,278 | $39 |
| Short return visit | 50 | $1,093 | $19 |
| Short return visit (20+ min) | 18 | $821 | $43 |
| Short return visit | 21 | $558 | $19 |
2015: 5 services
| New patient visit (45+ min) | 38 | $3,800 | $100 |
| Short return visit (20+ min) | 27 | $1,318 | $40 |
| Short return visit | 45 | $1,242 | $20 |
| Return visit (30+ min) | 15 | $1,071 | $67 |
| New patient visit (30+ min) | 12 | $597 | $50 |
2014: 6 services
| New patient visit (30+ min) | 73 | $4,558 | $62 |
| Short return visit (20+ min) | 64 | $4,414 | $45 |
| Diagnostic exam of bladder and urethra using an endoscope | 23 | $2,103 | $88 |
| Fitting and insertion of vaginal support device | 20 | $881 | $40 |
| Return visit (30+ min) | 12 | $839 | $70 |
| Short return visit | 23 | $513 | $21 |
2013: 3 services
| New patient visit (30+ min) | 28 | $1,845 | $66 |
| Short return visit (20+ min) | 14 | $789 | $44 |
| Short return visit | 12 | $301 | $21 |
Medicaid work
$3,690 in 2024
Medicaid paid $3,690 for 52 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 36 | $2,735 |
| Short return visit (20+ min) | 16 | $955 |
| 2024 | 52 | 2 | 18 | $3,690 |
| 2022 | 53 | 2 | 14 | $1,798 |
| 2021 | 24 | 1 | 12 | $406 |
| 2019 | 55 | 2 | 15 | $880 |
| 2018 | 12 | 1 | 12 | $92 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 40 | $992 |
| New patient visit (30+ min) | 13 | $807 |
2021
| Short return visit (20+ min) | 24 | $406 |
2019
| Short return visit (20+ min) | 42 | $781 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 13 | $99 |
2018
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 12 | $92 |
Drugs they prescribed that Part D paid
$90,311
Pharmacies billed $90,311 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
149 generic and 120 brand-name prescriptions · $90,311 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 60 | $37,275 | $621 |
| Myrbetriq | 47 | $36,574 | $778 |
| Estradiol | 46 | $4,842 | $105 |
| Yuvafem | 16 | $3,005 | $188 |
| Trospium Chloride Er | 15 | $2,230 | $149 |
See all 6 drugs
| Gemtesa | 60 | $37,275 | $621 |
| Myrbetriq | 47 | $36,574 | $778 |
| Estradiol | 46 | $4,842 | $105 |
| Yuvafem | 16 | $3,005 | $188 |
| Trospium Chloride Er | 15 | $2,230 | $149 |
| Trospium Chloride | 14 | $1,308 | $93 |
Year by year
| 2024 | 269 | 80 | None | 45% | $90,311 |
| 2023 | 203 | 70 | None | None | $67,336 |
| 2022 | 128 | 65 | None | 43% | $41,830 |
| 2021 | 183 | 72 | None | 30% | $36,146 |
| 2020 | 242 | 88 | None | None | $56,347 |
| 2019 | 360 | 115 | None | None | $68,154 |
| 2018 | 417 | 121 | None | 41% | $68,876 |
| 2017 | 424 | 126 | None | 42% | $59,880 |
| 2016 | 284 | 87 | None | 45% | $44,622 |
| 2015 | 186 | 71 | None | None | $24,156 |
| 2014 | 191 | 64 | 9% (17) | 43% | $16,938 |
| 2013 | 30 | 16 | None | 57% | $3,759 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Myrbetriq | 46 | $31,113 | $676 |
| Gemtesa | 28 | $17,206 | $614 |
| Estradiol | 35 | $5,428 | $155 |
| Yuvafem | 13 | $2,738 | $211 |
| Trospium Chloride | 18 | $954 | $53 |
2022: 2 drugs
| Myrbetriq | 33 | $25,981 | $787 |
| Estradiol | 19 | $1,982 | $104 |
2021: 5 drugs
| Myrbetriq | 41 | $20,284 | $495 |
| Estradiol | 38 | $4,463 | $117 |
| Trospium Chloride | 23 | $2,425 | $105 |
| Tolterodine Tartrate Er | 15 | $1,947 | $130 |
| Cephalexin | 12 | $138 | $11 |
2020: 5 drugs
| Myrbetriq | 44 | $23,647 | $537 |
| Estradiol | 56 | $9,063 | $162 |
| Premarin | 12 | $4,810 | $401 |
| Tolterodine Tartrate Er | 21 | $2,996 | $143 |
| Cephalexin | 20 | $277 | $14 |
2019: 9 drugs
| Myrbetriq | 67 | $32,450 | $484 |
| Estradiol | 44 | $6,938 | $158 |
| Premarin | 17 | $6,487 | $382 |
| Methenamine Hippurate | 20 | $2,970 | $148 |
| Trospium Chloride | 16 | $2,518 | $157 |
| Oxybutynin Chloride Er | 27 | $913 | $34 |
| Tolterodine Tartrate Er | 14 | $911 | $65 |
| Cephalexin | 27 | $373 | $14 |
| Nitrofurantoin Mono-Macro | 12 | $328 | $27 |
2018: 11 drugs
| Myrbetriq | 69 | $27,760 | $402 |
| Vesicare | 36 | $17,055 | $474 |
| Premarin | 13 | $4,757 | $366 |
| Estradiol | 12 | $2,108 | $176 |
| Trospium Chloride | 30 | $1,966 | $66 |
| Oxybutynin Chloride Er | 36 | $1,403 | $39 |
| Nitrofurantoin | 14 | $1,191 | $85 |
| Methenamine Hippurate | 12 | $931 | $78 |
| Clobetasol Propionate | 11 | $457 | $42 |
| Nitrofurantoin Mono-Macro | 15 | $455 | $30 |
| Cephalexin | 34 | $271 | $8 |
2017: 14 drugs
| Myrbetriq | 52 | $18,825 | $362 |
| Premarin | 20 | $6,866 | $343 |
| Vagifem | 28 | $6,206 | $222 |
| Vesicare | 19 | $6,147 | $324 |
| Estrace | 14 | $3,983 | $285 |
| Tolterodine Tartrate Er | 24 | $3,325 | $139 |
| Tolterodine | 12 | $1,625 | $135 |
| Oxybutynin Chloride Er | 35 | $1,470 | $42 |
| Methenamine Hippurate | 19 | $1,071 | $56 |
| Trospium Chloride | 16 | $1,052 | $66 |
| Nitrofurantoin Mono-Macro | 25 | $981 | $39 |
| Nitrofurantoin | 11 | $276 | $25 |
| Cephalexin | 24 | $196 | $8 |
| Sulfamethoxazole-Trimethoprim | 15 | $50 | $3 |
2016: 8 drugs
| Myrbetriq | 32 | $9,374 | $293 |
| Vesicare | 27 | $8,280 | $307 |
| Tolterodine Tartrate Er | 37 | $6,625 | $179 |
| Estrace | 20 | $5,261 | $263 |
| Tolterodine | 11 | $1,609 | $146 |
| Oxybutynin Chloride Er | 26 | $1,159 | $45 |
| Oxybutynin Chloride | 20 | $970 | $48 |
| Nitrofurantoin Mono-Macro | 11 | $296 | $27 |
2015: 6 drugs
| Vesicare | 25 | $6,088 | $244 |
| Premarin | 15 | $3,759 | $251 |
| Estrace | 11 | $2,459 | $224 |
| Methenamine Hippurate | 16 | $1,444 | $90 |
| Oxybutynin Chloride | 18 | $877 | $49 |
| Ibuprofen | 13 | $70 | $5 |
2014: 5 drugs
| Premarin | 23 | $4,950 | $215 |
| Methenamine Hippurate | 26 | $2,397 | $92 |
| Nitrofurantoin Mono-Macro | 17 | $373 | $22 |
| Hydrocodone-Acetaminophen | 15 | $135 | $9 |
| Ibuprofen | 15 | $69 | $5 |
Money from drug and device companies
$25 in 2025
| 2025 | 1 | 1 | None | $25 |
| 2024 | 3 | 8 | None | $376 |
| 2023 | 2 | 2 | None | $246 |
| 2022 | 1 | 1 | None | $103 |
| 2021 | 2 | 7 | None | $1,267 |
| 2020 | 1 | 3 | None | $187 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bluewind Medical | Revi | $25 | 1 payment
|
See the published payment
| Bluewind Medical | Meals · 2025-06-13 | Revi | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $376
| Coloplast | Altis | $281 | 4 payments
|
| Axonics | Axonics | $54 | 3 payments
|
| Boston Scientific | Solyx Sis System | $41 | 1 payment
|
2023: $246
| Medtronic | Interstim | $230 | 1 payment
|
| Axonics | Axonics | $16 | 1 payment
|
2022: $103
| Medtronic | Interstim | $103 | 1 payment
|
2021: $1,267
| Axonics | Bulkamid | $1,176 | 6 payments
|
| Medtronic | Interstim | $92 | 1 payment
|
2020: $187
| Medtronic USA | Interstim | $187 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1962660167
- Licence
- CA A112537, NY 248614California A112537: Current · expires 2027-11-30
- Trained
- University of Southern California Keck School of Medicine, 2006
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X); Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 200 Medical Plz, Los Angeles, Los Angeles, CA, 90095
- NPI first listed
- 2008-05-26
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 200 Medical Plz, Los Angeles, CA, 90095